Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
OWNR
HLB Therapeutics
★
HLB Slightly Increases Stake in HLB Therapeutics by 0.04% to 15.97% via Open Market Purchase, No Change in Control
06/02/2026, 10:53 AM
PERI
HLB Therapeutics
★
HLB Therapeutics Q1 2026: Operating Loss Widens, Debt Ratio Improves
05/15/2026, 05:37 PM